.

Investor

OncoCyte Senior Management Rings NYSE Opening Bell

Investor Relations

OncoCyte is focused on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer.

 

 

 

Corporate Profile

OncoCyte Chairman and CEO at Bell ringing ceremony

Stock Information
Events & Presentation

No upcoming events scheduled at this time.

Latest News
Don M. Bailey Appointed to OncoCyte Corporation’s Board of Directors
OncoCyte Corporation Announces the Closing of Two Private Placement Transactions Generating Gross Proceeds of $10.55 Million